PriceTargets.com logo

Stevanato Group - STVN Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
€20.56 As of 12/20/2024 09:57 PM ET
▼ -0.78 (-3.66%)

This chart shows the closing price for STVN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Stevanato Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for STVN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for STVN

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Stevanato Group in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €20.56.

This chart shows the closing price for STVN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 contributing investment analysts is to moderate buy stock in Stevanato Group. This rating has held steady since July 2023, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/13/2024Bank of AmericaBoost TargetBuy ➝ Buy$24.00 ➝ $26.00
12/13/2024Wolfe ResearchInitiated CoverageOutperform$28.00
12/3/2024Morgan StanleyReiterated RatingEqual Weight$24.00 ➝ $23.00
8/7/2024CitigroupLower TargetBuy ➝ Buy$30.00 ➝ $28.00
7/15/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$26.00 ➝ $22.00
4/22/2024Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$30.00 ➝ $30.00
4/22/2024BNP ParibasInitiated CoverageOutperform
3/25/2024StephensReiterated RatingOverweight ➝ Overweight$38.00
11/1/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$34.00 ➝ $30.00
11/1/2023Jefferies Financial GroupDowngradeBuy ➝ Hold$39.00 ➝ $29.00
9/25/2023StephensInitiated CoverageOverweight$33.00
9/19/2023CJS SecuritiesInitiated CoverageOutperform$36.00
8/30/2023KeyCorpBoost TargetOverweight ➝ Overweight$35.00 ➝ $37.00
8/24/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$34.00
7/31/2023Morgan StanleyBoost TargetOverweight$29.00 ➝ $34.00
7/31/2023Wells Fargo & CompanyBoost TargetOverweight$30.00 ➝ $35.00
6/16/2023Bank of AmericaBoost Target$32.00 ➝ $35.00
5/5/2023UBS GroupBoost Target$28.00 ➝ $29.00
5/5/2023Wells Fargo & CompanyBoost Target$27.00 ➝ $30.00
3/9/2023Wells Fargo & CompanyBoost TargetOverweight$21.00 ➝ $27.00
3/3/2023Morgan StanleyBoost TargetOverweight$22.00 ➝ $27.00
3/3/2023CitigroupBoost TargetBuy$22.00 ➝ $30.00
3/3/2023KeyCorpBoost TargetOverweight$26.00 ➝ $32.00
1/6/2023Morgan StanleyLower TargetOverweight$23.00 ➝ $22.00
11/9/2022Morgan StanleyBoost TargetOverweight$22.00 ➝ $23.00
8/15/2022Wells Fargo & CompanyBoost TargetOverweight$19.00 ➝ $21.00
4/25/2022Wells Fargo & CompanyLower TargetOverweight$21.00 ➝ $19.00
3/9/2022Morgan StanleyLower TargetOverweight$30.00 ➝ $22.00
3/9/2022Bank of AmericaLower TargetBuy$30.00 ➝ $24.00
3/9/2022Wells Fargo & CompanyLower TargetOverweight$26.00 ➝ $21.00
3/9/2022CitigroupLower TargetBuy$27.00 ➝ $23.00
9/27/2021Jefferies Financial GroupBoost TargetBuy$28.00 ➝ $34.50
9/22/2021KeyCorpBoost TargetPositive ➝ Overweight$27.00 ➝ $32.00
8/20/2021Morgan StanleyBoost TargetOverweight$26.00 ➝ $28.00
8/10/2021William BlairReiterated RatingOutperform
8/10/2021UBS GroupInitiated CoverageNeutral$22.00
8/10/2021CitigroupInitiated CoverageBuy$27.00
8/10/2021Wells Fargo & CompanyInitiated CoverageOverweight$24.00
8/10/2021KeyCorpInitiated CoverageOverweight$27.00
8/10/2021Jefferies Financial GroupInitiated CoverageBuy$25.00
8/10/2021Morgan StanleyInitiated CoverageOverweight$26.00
8/10/2021Bank of AmericaInitiated CoverageBuy$26.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.34 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 2 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 2 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 3 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 3 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Stevanato Group logo
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Read More

Today's Range

Now: €20.56
Low: €20.21
High: €21.50

50 Day Range

MA: €20.04
Low: €17.27
High: €23.67

52 Week Range

Now: €20.56
Low: €16.56
High: €34.73

Volume

614,800 shs

Average Volume

503,307 shs

Market Capitalization

$6.08 billion

P/E Ratio

43.74

Dividend Yield

0.25%

Beta

0.59

Frequently Asked Questions

What sell-side analysts currently cover shares of Stevanato Group?

The following equities research analysts have issued reports on Stevanato Group in the last year: Bank of America Co., BNP Paribas, Citigroup Inc., Morgan Stanley, Stephens, and Wolfe Research.
View the latest analyst ratings for STVN.

What is the current price target for Stevanato Group?

0 Wall Street analysts have set twelve-month price targets for Stevanato Group in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for Stevanato Group in the next year.
View the latest price targets for STVN.

What is the current consensus analyst rating for Stevanato Group?

Stevanato Group currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for STVN.

What other companies compete with Stevanato Group?

Other companies that are similar to Stevanato Group include Alpha Tau Medical, Anzu Special Acquisition Corp I, Bone Biologics, Bruush Oral Care and G Medical Innovations. Learn More about companies similar to Stevanato Group.

How do I contact Stevanato Group's investor relations team?

Stevanato Group's physical mailing address is PIOMBINO DESE (PD) VIA MOLINELLA 17, PADUA L6, 35017. The company's listed phone number is 39049931811 and its investor relations email address is [email protected]. The official website for Stevanato Group is www.stevanatogroup.com. Learn More about contacing Stevanato Group investor relations.